Frankline M. Onchiri

Frankline M. Onchiri

Auto-generated profile, based on publicly available information

Frankline M. Onchiri

Children’s Core for Biostatistics, Epidemiology and Analytics in Research and

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2016 in Journal of Surgical Research
Verified
Journal Article
Closed access
PDF file
SCSagar S. Chawla
Sagar S. Chawla
SGShailvi Gupta
Shailvi Gupta
FOFrankline M. Onchiri
Frankline M. Onchiri
EHElizabeth B. Habermann
Elizabeth B. Habermann
AKAdam L. Kushner
Adam L. Kushner
BSBarclay T. Stewart
Barclay T. Stewart

1 January 2014 in Interdisciplinary Perspectives on Infectious Diseases
Verified
Journal Article
Open access
PDF file
GKG. Kaguthi
G. Kaguthi
VNV. Nduba
V. Nduba
JNJ. Nyokabi
J. Nyokabi
FOF. Onchiri
F. Onchiri
RGR. Gie
R. Gie
MBM. Borgdorff
M. Borgdorff
The chest radiograph (CXR) is considered a key diagnostic tool for pediatric tuberculosis (TB) in clinical management and endpoint determination in TB vaccine trials. We set out to compare interrater agreement for TB diagnosis in western Kenya. A pediatric pulmonologist and radiologist (experts), a medical officer (M.O), and four clinical officers (C.Os) with basic training in pediatric CXR reading blindly assessed CXRs of infants who were TB suspects in a cohort study. C.Os had access to clinical findings for patient management. Weighted kappa scores summarized interrater agreement on lymphadenopathy and abnormalities consistent with TB. Sensitivity and specificity of raters were determined using microbiologically confirmed TB as the gold standard(n=8). A total of 691 radiographs were reviewed. Agreement on abnormalities consistent with TB was poor;k=0.14(95% CI: 0.10–0.18) and on lymphadenopathy moderatek=0.26(95% CI: 0.18–0.36). M.O [75% (95% CI: 34.9%–96.8%)] and C.Os [63% (95% CI: 24.5%–91.5%)] had high sensitivity for culture confirmed TB. TB vaccine trials utilizing expert agreement on CXR as a nonmicrobiologically confirmed endpoint will have reduced specificity and will underestimate vaccine efficacy. C.Os detected many of the bacteriologically confirmed cases; however, this must be interpreted cautiously as they were unblinded to clinical features.

15 May 2023 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
Yi-Hui ZhouYi-Hui Zhou
Yi-Hui Zhou
PGPaul J. Gallins
Paul J. Gallins
RPRhonda G. Pace
Rhonda G. Pace
HDHong Dang
Hong Dang
MAMelis A. Aksit
Melis A. Aksit
MKMichael R. Knowles
Michael R. Knowles
Rationale: Lung disease is the major cause of morbidity and mortality in persons with cystic fibrosis (pwCF). Variability in CF lung disease has substantial non-CFTR (CF transmembrane conductance regulator) genetic influence. Identification of genetic modifiers has prognostic and therapeutic importance. Objectives: Identify genetic modifier loci and genes/pathways associated with pulmonary disease severity. Methods: Whole-genome sequencing data on 4,248 unique pwCF with pancreatic insufficiency and lung function measures were combined with imputed genotypes from an additional 3,592 patients with pancreatic insufficiency from the United States, Canada, and France. This report describes association of approximately 15.9 million SNPs using the quantitative Kulich normal residual mortality-adjusted (KNoRMA) lung disease phenotype in 7,840 pwCF using premodulator lung function data. Measurements and Main Results: Testing included common and rare SNPs, transcriptome-wide association, gene-level, and pathway analyses. Pathway analyses identified novel associations with genes that have key roles in organ development, and we hypothesize that these genes may relate to dysanapsis and/or variability in lung repair. Results confirmed and extended previous genome-wide association study findings. These whole-genome sequencing data provide finely mapped genetic information to support mechanistic studies. No novel primary associations with common single variants or rare variants were found. Multilocus effects at chr5p13 (SLC9A3/CEP72) and chr11p13 (EHF/APIP) were identified. Variant effect size estimates at associated loci were consistently ordered across the cohorts, indicating possible age or birth cohort effects. Conclusions: This premodulator genomic, transcriptomic, and pathway association study of 7,840 pwCF will facilitate mechanistic and postmodulator genetic studies and the development of novel therapeutics for CF lung disease.

5 April 2016 in Neurology
Verified
Journal Article
Closed access
HCHyunmi Choi
Hyunmi Choi
APAlison Pack
Alison Pack
MEMitchell Elkind
Mitchell Elkind
WLW. T. Longstreth
W. T. Longstreth
FOFrankline Onchiri
Frankline Onchiri